Up to the minute news about Healthcare management. We'll find the latest Nursing news so you can chat about here.

Aetna bullish on Acomplia, not Byetta for obesity

CLEVELAND, Oct. 12 (Reuters) - Aetna Inc.'s (AET.N: Quote, Profile, Research) top pharmacist on Thursday said research on a highly anticipated drug for obesity called Acomplia is very encouraging -- a positive sign for drugmaker Sanofi-Aventis (SASY.PA:

Thu, 12 Oct 2006 20:27:00 GMT
Post your comments about this story here.